Daratumumab plus Lenalidomide/dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: MAIA update Meeting Abstract


Authors: Basu, S.; Kumar, S. K.; Moreau, P.; Bahlis, N.; Facon, T.; Plesner, T.; Orlowski, R. Z.; Nahi, H.; Hulin, C.; Quach, H.; Goldschmidt, H.; O'Dwyer, M.; Perrot, A.; Venner, C. P.; Weisel, K.; Raje, N.; Tiab, M.; Macro, M.; Frenzel, L.; Leleu, X.; Pei, H.; Krevvata, M.; Borgsten, F.; Usmani, S. Z.
Abstract Title: Daratumumab plus Lenalidomide/dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: MAIA update
Meeting Title: 63rd Annual Scientific Meeting of the British Society for Haematology
Journal Title: British Journal of Haematology
Volume: 201
Issue: Suppl. 1
Meeting Dates: 2023 Apr 23-25
Meeting Location: Birmingham, United Kingdom
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2023-04-01
Start Page: 17
End Page: 18
Language: English
ACCESSION: WOS:001049283000022
PROVIDER: wos
DOI: 10.1111/bjh.18718
Notes: Meeting Abstract: BSH23-OR21 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Saad Zafar Usmani
    296 Usmani